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Pantothenate, commonly referred to as vitamin B5, is an essential molecule in the metabolism of living organisms and forms the
core of coenzyme A. Unlike humans, some bacteria and plants are capable of de novo biosynthesis of pantothenate, making this
pathway a potential target for drug development. Francisella tularensis subsp. tularensis Schu S4 is a zoonotic bacterial pathogen
that is able to synthesize pantothenate but is lacking the known ketopantoate reductase (KPR) genes, panE and ilvC, found in the
canonical Escherichia coli pathway. Described herein is a gene encoding a novel KPR, for which we propose the name panG
(FTT1388), which is conserved in all sequenced Francisella species and is the sole KPR in Schu S4. Homologs of this KPR are
present in other pathogenic bacteria such as Enterococcus faecalis, Coxiella burnetii, and Clostridium difficile. Both the homolo-
gous gene from E. faecalis V583 (EF1861) and E. coli panE functionally complemented Francisella novicida lacking any KPR.
Furthermore, panG from F. novicida can complement an E. coli KPR double mutant. A Schu S4 panG strain is a pantothenate
auxotroph and was genetically and chemically complemented with panG in trans or with the addition of pantolactone. There was
no virulence defect in the Schu S4 panG strain compared to the wild type in a mouse model of pneumonic tularemia. In sum-
mary, we characterized the pantothenate pathway in Francisella novicida and F. tularensis and identified an unknown and previ-
ously uncharacterized KPR that can convert 2-dehydropantoate to pantoate, PanG.
Coenzyme A (CoA) is a ubiquitous cofactor found in all do-mains of life and plays a central role in carbon and energy
metabolism. Pantothenate forms the core of CoA; however, ani-
mals and some microorganisms lack the ability to synthesize pan-
tothenate. The pantothenate biosynthetic pathway is present in
some plants, fungi, bacteria, and archaea, making the pathway a
strong candidate for the discovery of novel antibiotics (1). The
pantothenate biosynthesis pathway was first genetically and
chemically defined in Escherichia coli and Salmonella enterica se-
rovar Typhimurium and is composed of four enzymes that use the
precursors 2-oxoisovalerate and L-aspartic acid to make pantothe-
nate (2, 3) (Fig. 1A). In one branch of the pathway, aspartate-1-
decarboxylase, PanD, converts L-aspartate to -alanine, and in a
separate branch two enzymes, PanB, a ketopantoate hydroxym-
ethyltransferase, and PanE, a ketopantoate reductase (KPR), con-
vert 2-oxoisovalerate to pantoate (4). The acetohydroxy acid
isomerase, IlvC, has also been shown to function as a KPR in E. coli
and S. Typhimurium, converting 2-dehydropantoate to pantoate,
similar to PanE (5, 6). In some species, e.g., Corynebacterium glu-
tamicum, IlvC is the sole KPR (7). In the final step of the panto-
thenate synthesis pathway, pantoate and -alanine are ligated by
the pantothenate synthase, PanC, to form pantothenate (8). The
published genomes of Francisella species contain panB, panC, and
panD. No homolog of E. coli PanE exists in the sequenced Franci-
sella genomes, and the most virulent strain of Francisella tularen-
sis, strain Schu S4, contains a frameshift mutation in ilvC, suggest-
ing a gap in the pantothenate biosynthetic pathway. Combining
the known nutritional requirements of Francisella species with the
sequenced genomes revealed that several strains require exoge-
nous pantothenate for growth (9). Interestingly, the most virulent
strain Schu S4 lacks a recognizable KPR and is a pantothenate
prototroph, while the live vaccine strain (LVS) has a KPR but is
clearly auxotrophic (10, 11). The genetic basis for differences in
the requirement for pantothenate among Francisella strains is not
known.
Francisella belongs to the Gammaproteobacteria and includes a
number of species that share greater than 95% genomic similarity
but differ in their ability to cause the disease tularemia in humans
(12, 13). Of all the species, Francisella tularensis subsp. tularensis is
the most virulent, exhibiting the highest morbidity and mortality
while also having a very low infectious dose, less than 10 bacteria
(11, 14). F. tularensis subsp. holarctica is also highly infectious for
humans, but clinical disease associated with this bacterium is typ-
ically mild (15). The LVS was derived from an F. tularensis subsp.
holarctica strain and is attenuated in humans. Francisella novicida
is rarely associated with human disease. As a facultative intracel-
lular pathogen, Francisella must acquire the nutrients needed to
support growth while within host cells. Several genetic screens for
replication-defective mutants have implicated biosynthetic path-
ways as contributing factors to the pathogenesis of Francisella spe-
cies (16). Interruption in genes involved in purine, aromatic
amino acid, and biotin biosynthesis results in attenuation of F.
tularensis within a mouse model of tularemia (17–20). Collec-
tively, these studies highlight the contribution of de novo biosyn-
thetic pathways to the ability of F. tularensis to survive within the
host environment. Using F. novicida, a genome-wide mutant
screen identified two genes contained in the putative pantothe-
nate operon that are required for pulmonary and systemic infec-
tions in mice. Inactivation of FTN_1351 (panG) or FTN_1355
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(coaX) resulted in mutant strains impaired in their ability to pro-
liferate in the organs of infected mice (21). Furthermore, tran-
scriptional profiling of F. tularensis revealed a dramatic increase in
expression of the F. tularensis homologs of panB, panC, and panD,
as well as the homologs of FTN_1351 (panG) and FTN_1355
(coaX) in strains grown within bone marrow-derived macro-
phages. This suggests that pantothenate biosynthesis may play a
role in the adaptation of Francisella to its intracellular niche (22).
The requirement for de novo synthesis of pantothenate in viru-
lence was demonstrated in a different intracellular pathogen, My-
cobacterium tuberculosis, for which a double mutant in panC and
panD was attenuated in both BALB/c and SCID mouse models of
infection (23). Collectively the published data suggest that panto-
thenate biosynthesis may contribute to the virulence of Franci-
sella, and the disparity in the requirement for pantothenate among
Francisella strains led us to investigate the genetic basis for panto-
thenate biosynthesis in several species of Francisella.
MATERIALS AND METHODS
Bacterial strains and cell culture. Escherichia coli strains (Table 1) were
grown at 37°C in Luria-Bertani (LB) broth, on LB agar, or in M9 minimal
medium supplemented with 1 g/ml thiamine, 3.4 mM valine, 3 mM
isoleucine, and 3 mM leucine. Unless otherwise noted, all F. tularensis
strains (Table 1) were grown at 37°C on chocolate agar (25 g brain heart
infusion [BHI] liter1, 10 g hemoglobin liter1, 15 g agar liter1) sup-
plemented with 1% IsoVitalex (Becton-Dickson) or in Chamberlain’s De-
fined Medium (CDM) (10). When necessary, hygromycin B (Hyg; Roche
Applied Science) was used at 200 g ml1, sucrose was used at 5% for E.
coli or 10% for F. tularensis (wt/vol), ampicillin (Amp; Roche Applied
Science) was used at 100 g ml1, L-arabinose (Sigma-Aldrich) was used
at 10 mM, and kanamycin (Km; Sigma-Aldrich) was used at 50 g ml1
for E. coli and 10 g ml1 for F. tularensis.
Growth assays. Growth assays for F. tularensis and F. novicida were
performed at 37°C while shaking in an Infinite M200 or M200 pro (Tecan)
apparatus in 96-well microtiter plates with absorbance (optical density at
600 nm [OD600]) monitored every 15 min. Bacterial strains grown over-
FIG 1 The biosynthetic pathway in Francisella species and the putative pantothenate operon. (A) The pantothenate biosynthetic pathway consists of two
converging arms. PanB, the ketopantoate hydroxymethyltransferase, converts 2-oxoisovalerate with tetrahydrofolate to form 2-dehydropantoate. The
substrate 2-dehydropantoate is then converted to (R)-pantoate by a number of enzymes, including IlvC and PanG, which are both capable of ketopantoate
reductase (KPR) activity. On the other branch of the pathway, PanD, an aspartate-1-decarboxylase, converts L-aspartic acid to -alanine. The pathway
converges with PanC, the pantothenate synthase that ligates (R)-pantoate with -alanine to form pantothenate. Molecules were made in PubChem
Compound on NCBI, and the pathway was constructed using KEGG metabolic pathway 00770 as a reference (http://www.genome.jp/kegg-bin/show
_pathway?FTN_00770). (B) The genomic organization of the putative pantothenate operon is conserved among sequenced Francisella strains containing
the panGBCD genes and the pantothenate kinase gene coaX. (C) Synteny diagram of the putative operon in F. novicida, F. tularensis LVS, F. tularensis Schu
S4, E. faecalis V583, and C. difficile 630 (35).
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night on chocolate agar were resuspended in phosphate-buffered saline
(PBS) to a Klett reading of 100 (approximately 1  109 CFU/ml). Resus-
pended cultures were diluted 1:20 into test media. The test medium con-
sisted of CDM or of CDM without calcium pantothenate (Sigma-Al-
drich). Genetic complementation in trans was evaluated in CDM lacking
pantothenate. Chemical complementation was evaluated in CDM lacking
pantothenate and supplemented with 100 M pantolactone (Sigma-Al-
drich), which can act in place of pantoate (31), or 100 M -alanine
(Sigma-Aldrich).
Construction of a double mutant using an Flp/Frt recombination in
F. novicida. To create the ilvC::Tnflp panG::Tn mutant (“flp” signifies a
cured Km cassette) we performed Flp-mediated recombination of
ilvC::Tn bearing the T20 insertion by introducing pFFlp-hyg, a tempera-
ture-sensitive plasmid, by electroporation and isolated Km-sensitive col-
onies grown at 30°C (25). Removal of the Km cassette left an 80-bp inser-
tion with the expected single FLP recombination target (FRT) site
remaining. Once the Km resistance marker was excised, pFFlp-hyg was
cured by growing the culture overnight at 37°C. The panG mutation was
introduced by transformation of genomic DNA from the panG::Tn strain
into the ilvC::Tnflp mutant and selecting for Km-resistant colonies, cre-
ating the double mutant (25). For genetic complementation, mutant
strains were transformed with their respective plasmids (29). Plasmids
were first transformed with the addition of 1 l of TypeOne Restriction
Inhibitor (Epicentre) into an FTN_1698::Tnflp restriction mutant strain
(25).
Construction of the E. coli ilvC::Flp panE::Kan double mutant using
FLP/FRT recombination and -Red recombineering. Using -Red re-
combineering, the ilvC::flp panE::Kan double mutant (“flp” signifies a
cured Km cassette) was created in E. coli by first introducing pFlp2 into
ilvC::Kan (JW3747-2) by electroporation and isolating Km-sensitive col-
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Genotype or description Source
Bacterial strains
E. coli DH10B F mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 endA1 araD139 (ara-leu) 7697 galU
galK rpsL nupG 
Invitrogen
E. coli Top10 F mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lac74 recA1 araD139 (ara-leu) 7697 galU galK
rpsL (Strr) endA1 nupG 
Invitrogen
E. coli panE::Kan JW0415-1 (araD-araB)567 lacZ4787(::rrnB-3) panE782::Kan  rph-(rhaD-rhaB)568 hsdR514 Keio Collection
E. coli ilvC::Kan JW3747-2 (araD-araB)567, lacZ4787(::rrnB-3) , rph-1, ilvC725::Kan (rhaD-rhaB)568 hsdR514 Keio Collection
F. novicida U112 F. tularensis subsp. novicida U112 (taxid, 401614) ATCC
F. holarctica LVS F. tularensis subsp. holarctica LVS (taxid, 376619) CDC
F. tularensis Schu S4 F. tularensis subsp. tularensis SCHU S4 (taxid, 177416) BEI Resources
E. faecalis Strain V583 Lance Thurlow
F. tularensis
panB::Tn strain tnfn1_pw060328p05q156 T20 (ISFn2/FRT) (FTN_1352) 24
panC::Tn strain tnfn1_pw060328p03q178 T20 (ISFn2/FRT) (FTN_1353) 24
panD::Tn strain tnfn1_pw060323p04q175 	Kan-2
 (FTN_1354) 24
panG::Tn strain tnfn1_pw060420p03q142 T20 (ISFn2/FRT) (FTN_1351) 24
ilvC::Tn strain tnfn1_pw060420p04q122 T20 (ISFn2/FRT) (FTN_1040) 24
FTN_1698::Tnflpa strain tnfn1_pw06032p08q164 This work
ilvC::Tnflpa panG::Tn strain tnfn1_pw060420p04q122flp/tnfn1_pw060420p03q142 This work
SKI01 F. tularensis Schu S4 panG This work
SKI02 F. novicida U112 ilvC::Tnflp panG::Tn with pEDL70 This work
SKI03 F. novicida U112 ilvC::Tnflp panG::Tn with pEDL71 This work
SKI04 F. novicida U112 ilvC::Tnflp panG::Tn with pSKI01 This work
SKI05 F. tularensis Schu S4 panG with pSKI01 This work
SKI06 F. tularensis Schu S4 panG with pMP831 empty vector control This work
SKI07 F. novicida U112 ilvC::Tnflp panG::Tn with pMP831 empty vector control This work
SKI08 F. holarctica LVS with panD from F. novicida U112 This work
SKI09 E. coli ilvC::Flp panE::Kan (JW0415-1 and JW3747-2) This work
SKI10 E. coli ilvC::Flp panE::Kan (JW0415-1 and JW3747-2) with pSKI01 This work
SKI11 E. coli ilvC::Flp panE::Kan (JW0415-1 and JW3747-2) with pSKI04 This work
Plasmids
pFFLP-hyg Carries flp under Francisella groEL promoter for recombination of FRT sites, TempSens, Hygr 25
pKD46 -Red recombineering plasmid, GenBank accession no. J02459.1, TempSens, Ampr 26
pFlp2 Carries flp recombinase for recombination of FRT sites, Ampr, Sucs 27
pEDL70 pMP822.panE, Hygr This work
pEDL71 pMP822.EF1861, Hygr This work
pSKI01 pMP831.panG FTN_1351, Hygr This work
pSKI02 pEDL50 with panG Schu S4 construct, Kmr, Sucs This work
pSKI03 pMP590 with panDU112 (FTN_1354), Km
r, Sucs This work
pSKI04 pMP822.ilvC, Hygr This work
pMP590 sacB suicide vector, Kmr, Sucs 28
pMP822 E. coli-F. tularensis shuttle vector, Hygr, blaB promoter 29
pMP831 E. coli-F. tularensis shuttle vector, Hygr 29
pEDL50 Conjugative sacB suicide vector, Hygr, Sucs 30
a “flp” signifies a cured kanamycin cassette.
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onies (26, 32). Removal of the kanamycin cassette left the signature single
FRT site of FLP/FRT recombination, creating ilvC::Flp. Once the Km
resistance marker was excised, pFlp2 was cured by growing the culture
overnight and plating on LB with 5% sucrose and without NaCl, and the
resulting colonies were screened for Amp sensitivity. Next, the -Red
recombineering plasmid pKD46 was introduced into the ilvC::Flp strain
by electroporation (27). When the absorbance of ilvC::Flp with pKD46
reached an OD600 of 0.1, 10 mM L-arabinose was added to induce expres-
sion of the -Red recombineering proteins: Gam, Bet, and Exo. The panE::
Kan mutation was introduced by transformation into the ilvC::Flp mutant
using PCR fragments generated from genomic DNA of panE::Kan
(JV0415-1), and colonies were selected for Km resistance.
F. novicida CoA levels. F. novicida was grown overnight on chocolate
agar plates at 37°C and then resuspended to an OD600 of 0.2 in 50 ml of
CDM lacking pantothenate and incubated for 5 h. The cells were pelleted
at 10,000  g for 5 min at 4°C and then resuspended in 0.5 ml of cold PBS
and snap-frozen in liquid nitrogen. The cells were thawed and bead beaten
2 times for 30 s at 4°C using lysing matrix B tubes (MP Biomedicals). Cell
debris was removed by centrifuging at 14,000  g for 2 min. Protein
concentration was determined by bicinchoninic acid (BCA) assay for each
sample. To deproteinize the lysates, 100 l of cold 1 N perchloric acid was
added to each sample and centrifuged at 14,000  g at 4°C for 2 min to
pellet precipitated protein. To neutralize the supernatant, 30 l of cold 3
M potassium bicarbonate was added to the samples. The concentrations
of CoA were determined for each sample using the PicoProbe Acetyl-CoA
assay kit (BioVision). The manufacturer’s protocol was followed, except
that the CoA quenching solution was not used, thereby allowing us to
determine the total concentration of CoA in each sample.
Replacing LVS panD (panDLVS) with F. novicida panD (panDU112).
The putative panD (FTN_1354) allele was PCR amplified from F. novicida
genomic DNA. The amplified DNA was subcloned into the TOPO pCRII
vector (Invitrogen) for propagation and maintenance. The BamHI-NotI
fragment containing the F. novicida panD allele was ligated into the sacB
suicide vector pMP590 and electroporated into LVS. Allelic exchange was
performed as previously described (28).
Deletion of FTT1388 (panG) in Schu S4. The putative panG
(FTT1388) allele plus 300 bp of DNA flanking each end was PCR ampli-
fied from F. tularensis Schu S4 genomic DNA. The amplified fragment was
cut with BamHI and NotI and then ligated into the sacB suicide vector,
pEDL50 (30). Using splice junction PCR, FTT1388 (panG) was elimi-
nated from the plasmid, creating a product with AatII restriction sites on
either end. The PCR product was digested with AatII and ligated, forming
pSKI01. Conjugation and allelic exchange were then performed to intro-
duce the clean in-frame deletion of panG into F. tularensis Schu S4 as
previously described (30, 33).
Mouse infection. Groups of 6-week-old C57BL/6 mice were anesthe-
tized and inoculated intranasally with 50 CFU of Schu S4 or Schu S4
panG (FTT1388). Mice were euthanized on days 1 and 3 postinfection,
and lungs, livers, and spleens were aseptically removed and homogenized
into 2 ml of sterile PBS using a Biojector (BIOSPEC Products, Inc.). Bac-
terial CFU for each organ were enumerated by plating serial dilutions of
tissue homogenates onto chocolate agar. The infection experiments were
approved and performed according to the animal care and use guidelines
established by IACUC.
RESULTS
Organization of the Francisella pantothenate biosynthesis
pathway. The advances in whole-genome sequencing have made
identification of metabolic pathways through the use of sequence
homology common. However, little experimental evidence is as-
sociated with these annotations, and gaps exist in many annotated
metabolic pathways, including those of F. tularensis and F. novi-
cida. Bioinformatics analysis suggests that the pantothenate bio-
synthesis pathway in F. novicida is much like that in E. coli, puta-
tively using PanB, PanD, PanC, and IlvC to convert L-aspartate
and 2-oxoisovalerate into pantothenate (Fig. 1A). Using F. novi-
cida BLASTP (NCBI) generated E values of 7e1069 for PanB,
6e1058 for PanC, 3e1020 for PanD, and 8e1022 for IlvC
relative to the characterized E. coli K-12 enzymes (34). Interest-
ingly, no homolog of E. coli PanE was identified in any of the 36
sequenced Francisella genomes. In addition, the ilvC gene in F.
tularensis Schu S4 contains a frameshift mutation that creates a
premature stop codon after amino acid 74, suggesting a gap in the
pantothenate biosynthetic pathway. LVS also has a truncation in
the panD gene, shortening the encoded protein from 111 amino
acids to 91 amino acids.
Unlike those of E. coli, the panB, panC, and panD genes of
Francisella species are organized into a predicted operon (Fig. 1B
and C), which is conserved in all the sequenced Francisella strains
(35). In addition to panBCD, this putative operon contains addi-
tional predicted open reading frames (ORFs) both 5= and 3= of
panBCD (Fig. 1C). There is an annotated ORF (panG) immedi-
ately 5= of panBCD that encodes an uncharacterized conserved
protein containing a domain of unknown function, DUF2520
(36). The ORF 3= of panBCD encodes a putative type III panto-
thenate kinase (CoaX), which catalyzes the first dedicated step in
CoA synthesis from pantothenate (37, 38). Francisella tularensis
also contains another coaX homolog, FTT0112, which is not part
of the putative operon.
The Francisella panBCD genes are required for growth in the
absence of pantothenate. We used the F. novicida comprehensive
two-allele transposon mutant library to assess the functionality of
individual components of the pantothenate biosynthesis pathway
(24). The pantothenate biosynthetic pathway in F. novicida was
characterized by complementing auxotrophic mutants with met-
abolic intermediates of pantothenate biosynthesis.
FTN_1352 (PanB) is a ketopantoate hydroxymethyl trans-
ferase that catalyzes the conversion of 2-oxoisovalerate to 2-dehy-
dropantoate (Fig. 1A). Functional inactivation of panB results in
mutant strains deficient in 2-dehydropantoate and loss of panto-
thenate synthesis. The panB::Tn mutant exhibited limited growth
in CDM lacking pantothenate, and growth of this mutant was
restored by supplementation with pantolactone (an alternative
substrate to pantoate) (Fig. 2A), thereby bypassing the PanB/IlvC
branch (31). Supplementation with -alanine alone was not suf-
ficient to support growth of this mutant (Fig. 2A), demonstrating
that FTN_1352 functions in the PanB/IlvC branch of the pathway
and is consistent with the annotation of FTN_1352 as panB.
FTN_1353 (PanC) encodes pantothenate synthase, which cat-
alyzes the formation of pantothenate from L-pantoate and -ala-
nine (Fig. 1A). Inactivation of panC results in a strain that requires
the addition of pantothenate for growth, and neither supplemen-
tation with pantolactone nor -alanine rescued growth. This in-
dicates that the FTN_1353 transposon mutation interrupts the
pantothenate biosynthesis pathway downstream of both the PanD
and PanB/IlvC branches, consistent with the phenotype of a pan-
tothenate synthase mutant (Fig. 2B).
FTN_1354 (PanD) is an L-aspartate -decarboxylase that
forms -alanine from L-aspartate (Fig. 1A), and inactivation of
panD results in a strain that is auxotrophic for -alanine. Consis-
tent with this phenotype, the panD::Tn mutant exhibited growth
defects in CDM lacking pantothenate and was rescued by the ad-
dition of -alanine. Supplementation with pantolactone failed to
restore growth of the panD::Tn mutant (Fig. 2C). These results
demonstrate that inactivation of FTN_1354 results in a loss of
Miller et al.
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-alanine synthesis and are consistent with the prediction that
FTN_1354 is a functional PanD (4).
FTN_1040 (IlvC) is known to function as an acetohydroxy acid
isomerase essential for branch chain amino acid synthesis and can
also function as a KPR in E. coli and S. Typhimurium (39). As the
only recognized enzyme with KPR activity within the F. novicida
genome, we were surprised to find that the ilvC::Tn transposon
mutant in F. novicida did not require pantothenate for growth
(Fig. 2D). This result suggested that there was another unrecog-
nized enzyme with sufficient KPR activity to support pantothe-
nate biosynthesis within F. novicida ilvC::Tn.
FTN_1351 (panG) is annotated as an uncharacterized con-
served gene and is part of the putative pantothenate operon, so we
tested the panG::Tn mutant’s pantothenate growth requirement.
Under each condition, the panG::Tn mutant grew, suggesting that
either PanG may not be involved in pantothenate synthesis or it is
functionally redundant with IlvC in KPR activity (Fig. 2E).
To determine if IlvC in F. novicida is a functional acetohydroxy
acid isomerase, we grew wild-type F. novicida U112 and ilvC::Tn
in CDM with and without branch chain amino acids (Fig. 2F).
Only wild-type U112 could grow in CDM without branch chain
amino acids, supporting our hypothesis that IlvC functions as an
acetohydroxy acid isomerase in F. novicida.
New class of ketopantoate reductase found in a number or
pathogenic organisms. Ketopantoate reductases (KPR) have a di-
nucleotide-binding domain called a Rossmann-fold that consists
of a  pocket to accommodate the coenzyme NADPH (40).
Within the Rossmann-fold is a consensus sequence, GXGXXG,
FIG 2 F. novicida functional complementation of panB::Tn, panC::Tn, panD::Tn, ilvC::Tn, and panG::Tn. Functional complementation of the pantothenate
biosynthetic genes in F. novicida transposon mutant strains grown in 96-well microtiter plates with absorbance (OD600) monitored every 15 min in CDM lacking
pantothenate (gray) either supplemented with -alanine (black dotted line), pantolactone (gray dotted line), or calcium pantothenate (black). Shown are growth
curves for panB::Tn (A), panC::Tn (B), panD::Tn (C), ilvC::Tn (D), and panG::Tn (E) mutants. (F) Growth of F. novicida U112 and ilvC::Tn in CDM with and
without branch chain amino acids: F. novicida U112 in CDM (black), ilvC::Tn in CDM (gray), U112 in CDM without branch chain amino acids (black dotted
line), and ilvC::Tn in CDM without branch chain amino acids (gray dotted line). Each growth curve was repeated a minimum of three times, and the graph
represents the means of three replicate experiments.
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which appears at the border between the first beta sheet and the
alpha helix (41). In E. coli the PanE N-terminal Rossmann-fold
domain and the C-terminal alpha-helical domain form a cleft, and
at that cleft is a conserved essential residue, Lys176, that forms the
hydrogen bond with C2 hydroxyl of pantoate (8). Pantoate also
forms additional interactions with conserved residues Ser244,
Asn98, and Asn180 (8). PanE and IlvC each have an N-terminal
NADB_Rossmann superfamily domain (36). IlvC is an acetohy-
droxy acid isomerase, which can also function as a KPR and re-
quires two cofactors, NADPH and Mg2, for the reduction of
2-dehydropantoate (42).
Bioinformatic analysis of PanG (FTN_1351) gave little insight
into its function. The comparison of the sequence to PanE and
other known KPR revealed no significant matches (5, 43). Phylo-
genetic analysis indicated that PanG is in a distinct group separate
from annotated KPRs using the Jukes-Cantor genetic distance
model (Fig. 3). There is no Rossmann domain identified in the
C-terminal region of FTN_1351, and the GXGXXG motif is not
present (41). The C-terminal region of FTN_1351 has a domain of
unknown function, DUF2520 (E value of 1.5e106), that often
accompanies an N-terminal Rossmann domain, suggesting that
the protein could function as an uncharacterized KPR (36). We
made a double mutation, ilvC::Tnflp panG::Tn, in F. novicida to
determine if FTN_1351 protein could function as a KPR. The
double mutant did not grow in medium lacking pantothenate
(Fig. 4A). Growth of the double mutant was restored when com-
FIG 3 Phylogenetic tree of known ketopantoate reductase proteins and PanG. The phylogenetic tree of known KPR proteins and PanG was generated using
Geneious Pro 5.5.6 Tree Builder with the cost matrix set to identity and Jukes-Cantor as the genetic distance model with no outgroups. All IlvC and PanE proteins
are annotated on PubMed to be involved in pantothenate synthesis, while all PanG proteins are annotated as hypothetical proteins. Enterococcus faecalis V583
PanG is annotated as hypothetical protein EF1861, Clostridium difficile 630 PanG is annotated as hypothetical protein CD630-15140, Coxiella burnetii RSA 493
PanG is annotated as hypothetical protein CBU_1660, Clostridium botulinum BKT015925 PanG is annotated as hypothetical protein CbC4_0183, and Desulfo-
tomaculum nigrificans DSM 574 PanG is annotated as hypothetical protein DUF2520.
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plemented in trans with panG expressed under its native pro-
moter, with ilvC driven by the Francisella blaB promoter or when
the media was supplemented with pantolactone (Fig. 4A and B).
This result confirms that IlvC is active in the F. novicida pantothe-
nate metabolic pathway and that FTN_1351 is a novel KPR gene,
which we named panG. Homologs of PanG are also found in other
pathogenic bacteria, including Enterococcus faecalis, Coxiella bur-
netii, and Clostridium difficile. BLASTP analysis of F. tularensis
Schu S4 PanG (FTT1388) revealed that this protein has significant
homology with Enterococcus faecalis V583 (EF1861) (E value 
2e1011), Coxiella burnetii (CBU1660) (E value  2e107), and
Clostridium difficile (CD630-15140) (E value  8e106) (34). In
E. faecalis and C. difficile, the panG genes are organized similarly in
putative pantothenate operons (Fig. 1B). Expression of the E.
faecalis V583 gene in F. novicida ilvC::Tnflp panG::Tn restored
growth of this mutant strain to near-wild-type levels in CDM lack-
ing pantothenate, confirming genetically that EF1861 is a func-
tional KPR (Fig. 4C). PanE, an analog KPR from E. coli (EC
1.1.1.169), is not present in any sequenced genome of Francisella,
and expression of this gene restored growth of F. novicida ilvC::
Tnflp panG::Tn in medium lacking pantothenate (Fig. 4D). Ex-
pression of the F. novicida panG gene in the E. coli KPR ilvC::flp
FIG 4 Genetic complementation of the F. novicida ilvC::Tnflp panG::Tn double mutant with F. novicida FTN_1351 panG, F. novicida ilvC, E. faecalis V583
(EF1861) panG, and E. coli panE and genetic complementation of the E. coli ilvC::Flp panE::Kan double mutant with F. novicida panG. Functional complemen-
tation experiments were carried out by growing Francisella in CDM lacking pantothenate in 96-well microtiter plates and measuring the absorbance (OD600)
every 15 min for 30 h. Competent F. novicida isolates were transformed with DNA. (A) pSKI01 carrying F. novicida panG (FTN_1351) driven by its native
promoter; (B) pSKI04 carrying ilvC from F. novicida driven by F. tularensis blaB promoter; (C) pEDL71 carrying panG from E. faecalis driven by F. tularensis blaB
promoter; (D) pEDL70 carrying panE from E. coli driven by F. tularensis blaB promoter. ilvC::Tn mutant grown in CDM lacking pantothenate containing empty
control vector pMP822/pMP831 (black), ilvC::Tnflp panG::Tn double mutant containing an empty control vector (gray), ilvC::Tnflp panG::Tn double mutant
containing the respective complementing plasmid (black dotted line), and ilvC::Tnflp panG::Tn double mutant grown in CDM supplemented with pantolactone
(gray dotted line). (E) E. coli ilvC::Flp panE::Kan double mutant complemented with pSKI01 carrying F. novicida panG driven by its native promoter. ilvC::Kan
mutant grown in M9 medium lacking pantothenate containing an empty control vector (black), ilvC::Flp panE::Kan double mutant containing an empty control
vector (gray), ilvC::Flp panE::Kan double mutant containing the respective complementing plasmid (black dotted line), and ilvC::Flp panE::Kan double mutant
grown in M9 supplemented with pantolactone (gray dotted line). Each growth curve experiment was repeated three times, and the graph represents the mean of
three replicate experiments.
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panE::kan double mutant restored growth in M9 minimal me-
dium lacking pantothenate, confirming genetically that PanG is a
functional KPR in E. coli (Fig. 4E).
Francisella novicida CoA levels. Coenzyme A is made from
pantothenate, cysteine, and adenosine and is an essential cofactor
in the first step of the tricarboxylic acid (TCA) cycle. To determine
the contribution of PanG and IlvC in the production of pantothe-
nate and subsequent CoA synthesis, we measured the concentra-
tion of CoA after 5 h of pantothenate depletion in wild-type F.
novicida and in the ilvC::Tn, panG::Tn, and ilvC::Tnflp panG::Tn
mutants. CoA levels were not significantly different between the
wild type and the ilvC::Tn mutant, suggesting that PanG can fulfill
the requirement for KPR activity in F. novicida (Fig. 5). The CoA
levels of the panG::Tn mutant strain were less than one-half of
wild-type levels and similar to levels of the ilvC::Tnflp panG::Tn
double mutant, suggesting that PanG is responsible for the major-
ity of KPR activity in F. novicida (Fig. 5).
Francisella tularensis LVS is a -alanine auxotroph. Early
studies revealed various nutritional requirements of Francisella
strains for pantothenate that appeared to correlate with virulence
in mice (9, 10). We assessed the requirement for pantothenate
with three different strains of Francisella: F. tularensis Schu S4, F.
tularensis LVS, and F. novicida U112. Each strain grew logarithmi-
cally in complete CDM (Fig. 6A to D). F. tularensis Schu S4 and F.
novicida U112 grew logarithmically under each dropout condi-
tion, suggesting that both strains have complete pantothenate bio-
synthesis pathways (Fig. 6). However, F. tularensis LVS failed to
grow in medium without pantothenate, indicating that LVS is a
pantothenate auxotroph. This result is in agreement with the ob-
servations of Chamberlain (10). Additionally, we observed that
growth of LVS could be restored by the addition of -alanine,
indicating that LVS lacks PanD activity (Fig. 6D). Comparison of
the nucleotide sequences of the putative panGBCD genes among
Francisella species revealed that F. tularensis LVS contains a base
substitution in the annotated panD gene. This substitution creates
a Q92 Ochre stop, resulting in a truncation of PanD by 20 amino
acids. To determine if LVS -alanine auxotrophy is due to a
nonfunctional panD, we replaced panDLVS with the functional
FIG 5 F. novicida CoA levels. CoA concentrations were measured from 50-ml
cultures of F. novicida wild-type, ilvC::Tn, panG::Tn, and ilvC::Tnflp panG::Tn
strains after 5 h of pantothenate depletion. All strains were grown to the same
OD600 and were normalized to total protein. The CoA levels represented are
the means  standard deviations (SD) for three independent experiments.
Statistical significance was determined by comparing the mutant values to
those of wild-type F. novicida. ***, P 	 0.0001; **, P 	 0.001.
FIG 6 F. tularensis Schu S4, F. tularensis LVS, and F. novicida growth in pantothenate dropout media. Growth curves of F. tularensis subsp. tularensis Schu S4
(black), F. tularensis subsp. holarctica LVS (black dotted line), and F. novicida U112 (gray) were monitored in CDM (A), CDM lacking pantothenate (B), CDM
lacking pantothenate supplemented with pantolactone (C), or CDM lacking pantothenate supplemented with -alanine (D). Each strain was grown in triplicate
in 96-well microtiter plates with absorbance (OD600) monitored every 15 min over 40 h. Each graph represents the mean of three replicate experiments.
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panDU112 via allelic exchange. As predicted, F. tularensis LVS har-
boring the panDU112 allele grew similarly in CDM with or without
added pantothenate (Fig. 7). This demonstrates that the observed
pantothenate auxotrophy of LVS results from a lack of PanD ac-
tivity. This truncation in PanD is unique to LVS, so we questioned
whether the lack of PanD activity contributed to the attenuated
phenotype of this strain. However, repair of panD activity in F.
tularensis LVS panDU112 did not confer a competitive advantage
relative to F. tularensis LVS panDLVS in a mouse model of pneu-
monic tularemia (data not shown). Thus, the LVS panD mutant
allele does not contribute to the attenuated phenotype of this
strain.
Francisella tularensis Schu S4 panG is a pantothenate
auxotroph. The panG (FTT1388) strain in Schu S4 requires
pantothenate for growth and can be rescued with the addition of
pantolactone in CDM lacking pantothenate or with panG ex-
pressed in trans. Schu S4 does not have a functional IlvC protein,
at least in regard to its KPR activity, due to a frameshift mutation,
making PanG the sole KPR. The panG strain can be comple-
mented in trans with the panG gene from F. novicida driven by the
F. novicida native promoter (Fig. 8B). Given that F. novicida panG
(FTN_1351) was identified in a screen to be required for virulence
in a mouse model of infection (21) and F. tularensis panG, panB,
panC, panD, and coaX genes were highly upregulated within bone
marrow-derived macrophages, pantothenate production and ul-
timately CoA synthesis may play a role in adaptation of Francisella
to its intracellular niche (22). We wanted to determine if the
panG mutation was important for infection in mice. With an
intranasal inoculum of 50 CFU, we saw no difference in lung, liver,
or spleen burdens when comparing panG to wild-type Schu S4 at
1 or 3 days postinoculation (Fig. 8C to E).
DISCUSSION
Pantothenate forms the core of CoA and is a precursor to acyl
carrier protein (ACP), making it essential in both energy and lipid
metabolism. We characterized the genes that function in panto-
thenate biosynthesis in Francisella using genetic and chemical
complementation approaches. These genes are organized into a
putative operon, which also included a gene coding for a hypo-
thetical protein, PanG (FTN_1351), which we discovered is a
novel KPR responsible for converting 2-dehydropantoate to pan-
toate. PanG (FTN_1351) does not have the known conserved
Rossmann-domain that is typically associated with KPRs. How-
ever, PanG does contain a C-terminal DUF2520, which usually
accompanies an N-terminal Rossmann-like domain. PanG res-
cued growth of an E. coli KPR double mutant in the absence of
pantothenate, and the panG homolog from E. faecalis V583
(EF1861) complemented KPR function in the F. novicida double
mutant. EF1861 also contains a predicted C-terminal DUF2520
domain in addition to a predicted N-terminal Rossmann-like do-
main. The panG genetic data (FTN_1351 and EF1861) suggest
that the DUF2520 domain is involved in KPR activity. Further
biochemical characterization of PanG needs to be done to deter-
mine structural binding motifs and enzymatic activity. Normally,
KPR proteins bind cofactors such as NAD or NADP; more work
needs to be done to characterize what cofactor is required for
PanG KPR activity. There is no GXGXXG motif in PanG, which is
responsible for NADP binding in E. coli; however, amino acids 11
to 16 are GXGXXA, which is a sequence found in mitochondrial
flavoenzymes that bind NADP (41). Using secondary-structure
predictions of PanG, the GXGXXA consensus sequence starts
right at the junction of a -sheet and an -helix that would be
compatible with a KPR  fold-forming sequence (44).
Functional complementation assays demonstrated that ex-
pression of panB, panC, and panD were each required for growth
of F. novicida in medium devoid of pantothenate. In regard to
KPR activity, only an ilvC::Tnflp panG::Tn double mutant of F.
novicida created a pantothenate auxotroph, demonstrating that
PanG is functionally redundant with the acetohydroxy acid
isomerase, IlvC. Both the panG homolog from E. faecalis V583 and
the known panE gene encoding a KPR from E. coli DH10B could
functionally complement the F. novicida ilvC::Tnflp panG::Tn
KPR double mutant. CoA levels were not significantly different
between the wild type and the ilvC::Tn mutant after 5 h of panto-
thenate depletion, demonstrating that PanG can fulfill the re-
quirement for KPR activity in F. novicida. CoA levels in both the
panG::Tn mutant strain and the ilvC::Tnflp panG::Tn double mu-
tant were less than one-half the concentration of the wild type,
suggesting that PanG is responsible for the majority of KPR activ-
ity in F. novicida. We also found that the LVS strain is a -alanine
auxotroph resulting from a base substitution in panD causing an
amino acid substitution that shortens the aspartate-1-decarboxyl-
ase. While the lack of PanD activity appears to be unique to the
LVS strain, it does not contribute to the attenuation of this strain
in mice. In addition, the Schu S4 frameshift in ilvC produced a
nonfunctional protein in regard to KPR activity. We demon-
FIG 7 Repair of F. tularensis LVS -alanine auxotrophy. Growth curves of LVS (gray) and LVS with the native panDLVS replaced with panDU112 from F. novicida
U112 (black). Each strain was monitored in CDM (A) or CDM lacking pantothenate (B). Both strains were grown in 96-well microtiter plates, and the OD600 was
determined every 15 min for 24 h. Each graph represents the mean OD600 of three replicate experiments.
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strated that PanG is the sole KPR in Schu S4, since creating an
in-frame panG deletion resulted in a pantothenate auxotroph.
However, the Schu S4 panG strain did not have a demonstrable
virulence defect in a mouse model of pneumonic tularemia. It is
not clear what molecule this mutant acquired from the host or
where it acquired it to satisfy its pantothenate requirement. Given
that mice have a blood plasma pantothenate level of 20 M while
humans have only 2 to 4 M, it is possible that an F. tularensis
pantothenate synthesis mutant could be attenuated in humans
but not mice (45). It is possible that mice have excess pantothenate
in their bloodstream, considering their diet is supplemented with
pantothenate in addition to that naturally acquired from their gut
flora. E. coli can produce and secrete 15 times more pantothenate
than required for CoA biosynthesis, and ruminants obtain suffi-
cient quantities of pantothenate from their gut microorganisms
(46, 47). Virtually all bacteria, including F. tularensis, can take up
pantothenate, but F. tularensis does not have an annotated panF
homolog responsible for sodium-cotransport of pantothenate (1).
It appears that F. tularensis is able to obtain pantothenate, a CoA
precursor (such as phosphopantetheine), or CoA from the host
FIG 8 F. tularensis subsp. tularensis Schu S4 panG growth and virulence phenotype. (A) Chemical complementation of Schu S4 panG grown in CDM (black),
CDM lacking pantothenate (black dotted line), CDM lacking pantothenate supplemented with -alanine (gray), and CDM lacking pantothenate supplemented
with pantolactone (gray dotted line). (B) Genetic complementation of F. tularensis subsp. tularensis Schu S4 panG with F. novicida panG expressed by the native
promoter in the shuttle vector pMP831. Growth curve of F. tularensis subsp. tularensis Schu S4 (black), F. tularensis subsp. tularensis Schu S4 panG with pMP831
(empty control vector) (gray), and F. tularensis subsp. tularensis Schu S4 panG complemented with pSKI01 (black dotted line). All growth curves were done in
triplicate, monitoring absorbance (OD600) in a 96-well microtiter dish. Graphs represent the mean absorbance at OD600. (C to E) Recovery of Schu S4 or Schu
S4 panG mutant in mice following intranasal inoculation. C57BL/6 mice were infected intranasally with either wild-type Schu S4 (black circles) or Schu S4
panG (gray triangles) at a lethal dose of 50 CFU. Mice were euthanized on days 1 and 3 postinfection, and lung burdens (C), liver burdens (D), and spleen
burdens (E) were determined and graphed. Each symbol represents data from a single mouse. There were no significant differences in recovery of mutant versus
wild-type organisms from any organ at any time point as determined by the nonparametric Mann-Whitney test.
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and is likely storing sufficient quantities of pantothenate to sup-
port logarithmic growth for several rounds of replication while
inside cells, where pantothenate may be limited. Pantothenate is
immediately phosphorylated once taken up by host cells and
could affect the ability of F. tularensis to acquire pantothenate.
Further work will be needed to determine how F. tularensis ac-
quires pantothenate or other substituents of CoA from the host. It
may be a valuable endeavor to look further down in the CoA
pathway for potential drug targets for Francisella tularensis, start-
ing with the putative type III pantothenate kinases (FTT1392 and
FTT0112), which is the first committed step in CoA biosynthesis.
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